SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001575872-15-000007
Filing Date
2015-02-18
Accepted
2015-02-18 15:11:50
Documents
9
Period of Report
2014-07-31

Document Format Files

Seq Description Document Type Size
1 10q.htm 10-Q 148768
2 ex31-1.htm EX-31 10714
3 ex32-1.htm EX-32 4304
  Complete submission text file 0001575872-15-000007.txt   1346369

Data Files

Seq Description Document Type Size
4 cik0001565220-20140731.xml EX-101.INS 105750
5 cik0001565220-20140731.xsd EX-101.SCH 16302
6 cik0001565220-20140731_cal.xml EX-101.CAL 14427
7 cik0001565220-20140731_def.xml EX-101.DEF 71123
8 cik0001565220-20140731_lab.xml EX-101.LAB 91462
9 cik0001565220-20140731_pre.xml EX-101.PRE 90606
Mailing Address 203 ? 29 GERVAIS DRIVE TORONTO A6 M3C 1Y9
Business Address 203 ? 29 GERVAIS DRIVE TORONTO A6 M3C 1Y9 79025104036
FV Pharma International Corp. (Filer) CIK: 0001565220 (see all company filings)

IRS No.: 680682594 | State of Incorp.: NV | Fiscal Year End: 0131
Type: 10-Q | Act: 34 | File No.: 333-187669 | Film No.: 15627618
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries